Lilly Announces an Extension to 2015 Research Collaboration deal with Dana Farber Cancer Institute

 Lilly Announces an Extension to 2015 Research Collaboration deal with Dana Farber Cancer Institute

Lilly Announces an Extension to 2015 Research Collaboration deal with Dana Farber Cancer Institute

Shots:
  • The extension provides a better understanding to clinicians and initial funding discoveries, molecular analyses, design and conduct of samples for new discoveries in cancer
  • Agreement defines that Dana has right to perform multiple clinical and preclinical trials adding in Lilly’s pipeline
  • Evaluated compound ownership will remain under Lilly
Click here to read full press release/ article | Ref: Lilly | Image: Lilly

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post